- Home
- RMTI vs RVPH Comparison
RMTI vs RVPH Comparison
Compare RMTI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMTI
- RVPH
- Stock Information
- Founded
- RMTI 1994
- RVPH 2006
- Country
- RMTI United States
- RVPH United States
- Employees
- RMTI N/A
- RVPH N/A
- Industry
- RMTI Biotechnology: Pharmaceutical Preparations
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- RMTI Health Care
- RVPH Health Care
- Exchange
- RMTI Nasdaq
- RVPH Nasdaq
- Market Cap
- RMTI 33.0M
- RVPH 36.7M
- IPO Year
- RMTI 1998
- RVPH N/A
- Fundamental
- Price
- RMTI $0.91
- RVPH $0.70
- Analyst Decision
- RMTI Strong Buy
- RVPH Strong Buy
- Analyst Count
- RMTI 2
- RVPH 5
- Target Price
- RMTI $4.00
- RVPH $9.00
- AVG Volume (30 Days)
- RMTI 163.6K
- RVPH 662.3K
- Earning Date
- RMTI 08-07-2025
- RVPH 08-13-2025
- Dividend Yield
- RMTI N/A
- RVPH N/A
- EPS Growth
- RMTI N/A
- RVPH N/A
- EPS
- RMTI N/A
- RVPH N/A
- Revenue
- RMTI $97,727,000.00
- RVPH N/A
- Revenue This Year
- RMTI N/A
- RVPH N/A
- Revenue Next Year
- RMTI $11.16
- RVPH N/A
- P/E Ratio
- RMTI N/A
- RVPH N/A
- Revenue Growth
- RMTI 12.82
- RVPH N/A
- 52 Week Low
- RMTI $0.86
- RVPH $0.49
- 52 Week High
- RMTI $5.15
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- RMTI 39.80
- RVPH 39.46
- Support Level
- RMTI $0.91
- RVPH $0.67
- Resistance Level
- RMTI $1.00
- RVPH $0.90
- Average True Range (ATR)
- RMTI 0.05
- RVPH 0.06
- MACD
- RMTI -0.00
- RVPH -0.02
- Stochastic Oscillator
- RMTI 11.71
- RVPH 11.36
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.